reglab/housing_qa huggingface dataset:
WY Stat § 33-24-145 (2021)
2021 Wyoming Statutes|Title 33 - Professions and Occupations|Chapter 24 - Pharmacy|Article 1 - In General|Section 33-24-145 - Powers and Duties of Agents, Inspectors and Board Members.

33-24-145. Powers and duties of agents, inspectors and board members.| (a) The board, its agents and inspectors may specially, but not exclusively, examine and inspect all activities in this state undertaken in compliance with W.S. 33-24-101 through 33-24-301 which appear to be contrary to or in violation of W.S. 33-24-101 through 33-24-301, to procure enforcement and to check for violations and provide for enforcement of related federal laws and regulations. The inspectors may also determine if practitioners' records are adequately kept in a manner reflecting professional responsibility and may provide legislative recommendations if records are not found to be adequately maintained.  (b) The board, its agents and inspectors shall examine and inspect drug manufacturers, distributors and wholesalers, licensed pursuant to W.S. 33-24-153.
WY Stat § 33-24-146 (2021)
2021 Wyoming Statutes|Title 33 - Professions and Occupations|Chapter 24 - Pharmacy|Article 1 - In General|Section 33-24-146 - Citation.

33-24-146. Citation.| This act is known and may be cited as the "Wyoming Generic Drug Substitution Act".
WY Stat § 33-24-147 (2021)
2021 Wyoming Statutes|Title 33 - Professions and Occupations|Chapter 24 - Pharmacy|Article 1 - In General|Section 33-24-147 - Definitions.

33-24-147. Definitions.| (a) As used in this act:  (i) "Brand name" means the proprietary or trade name selected by the manufacturer and placed upon a drug, its container, label or wrapping at the time of packaging;  (ii) "Generically equivalent drug" means a drug that contains identical active ingredients in the identical dosage forms, but not necessarily containing the same inactive ingredients, that meet the identical compendial or other applicable standards of identity, strength, quality and purity, including potency, and, where applicable, content uniformity, disintegration times or dissolution rates, as the prescribed brand name drug, and, if applicable, the manufacturer or distributor holds either an approved new drug application or an approved abbreviated new drug application unless other approval by law or from the Federal Food and Drug Administration is required. A generically equivalent drug shall bear an "AB" or higher rating in the Federal Food and Drug Administration Approved Drug Products with Therapeutic Equivalence Evaluations;  (iii) "Generic name" means the chemical or generic name, as determined by the United States Adopted Names (USAN) and accepted by the Federal Food and Drug Administration (FDA), of those drug products having the same active chemical ingredients;  (iv) "Substitute" means to dispense a generically equivalent drug or interchangeable biological product in place of the prescription ordered or prescribed;  (v) "Therapeutically equivalent" means drugs that will provide the same bioavailability or bioequivalence when administered to an individual in the same dosage regimen;  (vi) "Biological product" means as defined in 42 U.S.C. 262(i)(1);  (vii) "Interchangeable biological product" means a biological product that the United States food and drug administration has:  (A) Licensed and determined meets the standards for interchangeability under 42 U.S.C. 262(k)(4); or  (B) Determined is therapeutically equivalent to the prescription ordered or prescribed, as set forth in the latest edition or supplement to the Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) issued by the United States food and drug administration.  (viii) "This act" means W.S. 33-24-146 through 33-24-151.
WY Stat § 33-24-148 (2021)
2021 Wyoming Statutes|Title 33 - Professions and Occupations|Chapter 24 - Pharmacy|Article 1 - In General|Section 33-24-148 - Conditions for Drug Substitution.

33-24-148. Conditions for drug substitution.| (a) Repealed By Laws 2001, Ch. 54, § 2.  (b) Except as limited by W.S. 33-24-149(b) or when the practitioner has clearly indicated substitution is not permitted, a pharmacist may substitute:  (i) A drug product with the same generic name in the identical strength, quantity, dose and dosage form as the prescribed drug, provided the substituted product or drug meets all requirements specified in W.S. 33-24-147(a)(ii);  (ii) An interchangeable biological product.  (c) Repealed By Laws 2001, Ch. 54, § 2.  (d) Repealed By Laws 2001, Ch. 54, § 2.  (e) A pharmacist may not substitute a generically equivalent drug unless it has been manufactured with the following minimum manufacturing standards and practices by a manufacturer who:  (i) Marks capsules and tablets with an identification code or monogram;  (ii) Labels products with their expiration date;  (iii) Maintains reasonable resources for product information;  (iv) Maintains recall capabilities for unsafe or defective drugs.  (f) Repealed By Laws 2001, Ch. 54, § 2.  (g) When a practitioner orally communicates a prescription and prohibits substitution of an interchangeable biological product or generically equivalent drug, the pharmacist shall make reasonable efforts to obtain a written prescription from the practitioner with the phrase "brand medically necessary" written on the face of the prescription in his own handwriting.
WY Stat § 33-24-150 (2021)
2021 Wyoming Statutes|Title 33 - Professions and Occupations|Chapter 24 - Pharmacy|Article 1 - In General|Section 33-24-150 - Pharmacist's Liability.

33-24-150. Pharmacist's liability.| Any pharmacist who selects the drug product to be dispensed shall assume no greater liability for selecting the dispensed product as would be incurred in filling a prescription for a drug product prescribed by generic name.
WY Stat § 33-24-151 (2021)
2021 Wyoming Statutes|Title 33 - Professions and Occupations|Chapter 24 - Pharmacy|Article 1 - In General|Section 33-24-151 - Substitution Not Considered Practice of Medicine; Individual Causes of Action.

33-24-151. Substitution not considered practice of medicine; individual causes of action.| (a) The substitution of any dangerous substance by a registered pharmacist or a registered pharmacy intern under his direct supervision does not under this act constitute the practice of medicine.  (b) This act shall not be construed to deny any individual a cause of action against a pharmacist or his employer for violations of this act, including failure to observe accepted standards of care of the pharmaceutical profession.
WY Stat § 33-24-154 (2021)
2021 Wyoming Statutes|Title 33 - Professions and Occupations|Chapter 24 - Pharmacy|Article 1 - In General|Section 33-24-154 - Emergency Administration of Controlled Substances.

33-24-154. Emergency administration of controlled substances.| Notwithstanding any other provision of this act or the Wyoming Controlled Substances Act, the board, by rule or regulation, may authorize nursing homes, hospices, extended care facilities or intermediate care facilities to maintain a limited supply of controlled substances or other drugs on the premises for emergency administration to the residents and patients therein without being subject to the licensure requirements of this act.
WY Stat § 33-24-155 (2021)
2021 Wyoming Statutes|Title 33 - Professions and Occupations|Chapter 24 - Pharmacy|Article 1 - In General|Section 33-24-155 - Reports Required to State Health Officer.

33-24-155. Reports required to state health officer.| (a) As provided by department of health rule and regulation, a pharmacist shall report in the manner established through published reporting procedures provided to each licensed pharmacist, any unusually high volume of any type of prescription filled, unusual trend in pharmacy visits or unusual trend in nonprescription medication sales that the pharmacist has reason to believe is related to a public health emergency.  (b) Pursuant to department of health rule and regulation, there may be a review of medical records by the state health officer, his designee or their designated health care representative who shall be under the direct supervision of the state health officer or his designee to confirm diagnosis, investigate causes or identify other cases of disease conditions in a region, community or workplace in the state to determine if proper measures have been taken to protect the public health and safety. Notwithstanding any other provision of law, the review of records during a public health emergency or disease outbreak may occur without patient consent, but shall be kept confidential and shall be restricted to information necessary for the control, investigation and prevention of any disease condition dangerous to the public health. Any person who receives medical information under this subsection shall not disclose that information for any other purpose than the investigation and any disease control effort. Any violation of this subsection is a misdemeanor punishable by imprisonment for not more than six (6) months, a fine of not more than one thousand dollars ($1,000.00), or both.
WY Stat § 33-24-156 (2021)
2021 Wyoming Statutes|Title 33 - Professions and Occupations|Chapter 24 - Pharmacy|Article 1 - In General|Section 33-24-156 - Telepharmacy Practice Authorized.

33-24-156. Telepharmacy practice authorized.| (a) The board pursuant to its rules and regulations may authorize a resident pharmacy licensee to store and dispense prescription drugs as provided in subsection (b) of this section through a telepharmacy located at a site at least ten (10) miles from a licensed pharmacy except this ten (10) mile restriction does not apply:  (i) In counties with a city of fifty thousand (50,000) or more persons as shown in the most recent federal census; or  (ii) To any facility owned or leased by the state or any subdivision of the state; or  (iii) To any facility located in a hospital or clinic setting.  (b) Telepharmacies shall include the following minimum features:  (i) Storage, security and dispensing of prescription drugs only:  (A) In unit of issue packages;  (B) Through a system which dispenses tablets or capsules from an enclosed and lockable cabinet directly into a prescription vial and prints and applies a prescription label to the vial; or  (C) By manually dispensing tablets, capsules or liquids from a stock bottle into a prescription vial and affixing a prescription label to the vial.  (ii) Connection by a secure communication system to the parent pharmacy, with the capability of live video and audio communication with a licensed pharmacist at the parent pharmacy during hours of operation;  (iii) Adequate provision for security, including verification of customer identity and prescription information;  (iv) Automated inventory control using bar codes, radio frequency tags or a similar identification system;  (v) Prominent display of the name, address and toll free telephone number of the parent pharmacy;  (vi) Telepharmacies shall be supervised by a parent pharmacy and a licensed pharmacist and shall be staffed during hours of operation by a licensed pharmacist, certified pharmacy technician or registered pharmacy intern.  (c) A telepharmacy system operated as provided in this act and in accord with rules and regulations of the board is deemed to be operated under the charge of a licensed pharmacist for purposes of W.S. 33-24-113(b).  (d) A licensed pharmacist who supervises a telepharmacy shall complete an inspection of the telepharmacy at a frequency specified by the board of pharmacy. Inspection criteria shall be developed by the state board of pharmacy and all inspection criteria shall be included in the policies and procedures applicable to each telepharmacy site. Inspection reports shall be prepared pursuant to standards adopted by the board of pharmacy and shall be maintained by each telepharmacy until the next state board of pharmacy inspection.
WY Stat § 33-24-157 (2021)
2021 Wyoming Statutes|Title 33 - Professions and Occupations|Chapter 24 - Pharmacy|Article 1 - In General|Section 33-24-157 - Immunization Administration.

33-24-157. Immunization administration.| (a) A pharmacist licensed under this act may only prescribe and administer immunizations recommended for healthy individuals age seven (7) and older in a private space utilized for counseling and administering immunizations to ensure patient safety and confidentiality as authorized by the board. Parental consent shall be required for prescriptions for immunizations and for administration of immunizations pursuant to this section for any minor child. A pharmacist administering vaccinations pursuant to this section shall enter a record of the immunization in the Wyoming immunization registry operated by the department of health. Nothing in this subsection shall be deemed to require any pharmacist to administer immunizations to individuals who are less than thirteen (13) years of age. No employer shall discriminate against a pharmacist on the basis that the pharmacist determines not to administer immunizations to individuals who are less than thirteen (13) years of age.  (b) A pharmacist licensed under this act may administer immunizations to adults who are considered high risk only by prescription from a licensed physician.  (c) The board, in cooperation with the Wyoming state board of medicine, shall adopt rules specifying immunizations allowed under this act and the requirements a pharmacist shall meet in order to prescribe and administer immunizations, including requirements for spaces in which immunizations shall be administered by a pharmacist.
WY Stat § 33-24-158 (2021)
2021 Wyoming Statutes|Title 33 - Professions and Occupations|Chapter 24 - Pharmacy|Article 1 - In General|Section 33-24-158 - Prescription of Opiate Antagonist by Pharmacist.

33-24-158. Prescription of opiate antagonist by pharmacist.| (a) A pharmacist licensed under this act may prescribe an opiate antagonist in accordance with the Emergency Administration of Opiate Antagonist Act.  (b) The board, in cooperation with the Wyoming state board of medicine, shall adopt rules specifying the requirements a pharmacist shall meet in order to prescribe an opiate antagonist.
WY Stat § 33-24-201 (2021)
2021 Wyoming Statutes|Title 33 - Professions and Occupations|Chapter 24 - Pharmacy|Article 2 - Wyoming Drug Identification Act|Section 33-24-201 - Short Title.

33-24-201. Short Title.| This article shall be known and may be cited as the "Wyoming Drug Identification Act".
WY Stat § 33-24-202 (2021)
2021 Wyoming Statutes|Title 33 - Professions and Occupations|Chapter 24 - Pharmacy|Article 2 - Wyoming Drug Identification Act|Section 33-24-202 - Definitions.

33-24-202. Definitions.| (a) As used in this article:  (i) "Code imprint" means a series of letters or numbers assigned by the manufacturer or distributor to a specific drug, or marks or monograms unique to the manufacturer or distributor of the drug, or both;  (ii) "Dangerous substance" means any drug defined under W.S. 33-24-125;  (iii) "Distributor" means a person who distributes for resale a drug in solid dosage form under his own label even though he is not the actual manufacturer of the drug;  (iv) "Solid dosage form" means capsules or tablets intended for oral use;  (v) Repealed by Laws 2019, ch. 186, § 2.
WY Stat § 33-24-203 (2021)
2021 Wyoming Statutes|Title 33 - Professions and Occupations|Chapter 24 - Pharmacy|Article 2 - Wyoming Drug Identification Act|Section 33-24-203 - Code Imprint Required for the Manufacture and Distribution of Dangerous Substances; Listing of Substances With Board of Pharmacy; Exceptions; Exemptions.

33-24-203. Code imprint required for the manufacture and distribution of dangerous substances; listing of substances with board of pharmacy; exceptions; exemptions.| (a) No dangerous substance in solid dosage form shall be manufactured or distributed in this state unless it is clearly marked or imprinted with a code imprint identifying the drug and the manufacturer or distributor of the drug.  (b) All manufacturers and distributors of dangerous substances in solid dosage form shall provide upon request to the Wyoming board of pharmacy a listing of all dangerous substances identifying by code imprint the manufacturer and the specific type of drug. The listing shall at all times be kept current by all manufacturers and distributors subject to this article.  (c) This article shall not apply to nonnarcotic, nonprescription, prepackaged medicinal preparations contained in distinctive and original unbroken containers, when the medicinal preparations are identified by and sold under a trade name of the manufacturer or primary distributor and are sold or offered for sale to the general public, if the articles meet the requirements of state and federal food, drug and cosmetic laws.  (d) The Wyoming board of pharmacy may grant exemptions from the requirements of this article upon application by any drug manufacturer or distributor showing size, physical characteristics or other unique characteristics which render the application of a code imprint to a drug subject to this article impractical or impossible. Any exemption granted by the board shall be included by the manufacturer or distributor in the listing required by subsection (b) of this section, describing the physical characteristics and type of drug to which the exemption applies.
WY Stat § 33-24-204 (2021)
2021 Wyoming Statutes|Title 33 - Professions and Occupations|Chapter 24 - Pharmacy|Article 2 - Wyoming Drug Identification Act|Section 33-24-204 - Violations; Seizure by the Board of Pharmacy.

33-24-204. Violations; seizure by the board of pharmacy.| All dangerous substances in solid dosage form that are possessed, distributed, sold or offered for sale in violation of the provisions of this article are deemed contraband and shall be seized by the Wyoming board of pharmacy and summarily forfeited to the state.
WY Stat § 33-26-101 (2021)
2021 Wyoming Statutes|Title 33 - Professions and Occupations|Chapter 26 - Physicians and Surgeons|Article 1 - General Provisions|Section 33-26-101 - Short Title.

33-26-101. Short title.| This chapter is known and may be cited as the "Medical Practice Act".
WY Stat § 33-26-103 (2021)
2021 Wyoming Statutes|Title 33 - Professions and Occupations|Chapter 26 - Physicians and Surgeons|Article 1 - General Provisions|Section 33-26-103 - Applicability of Chapter.

33-26-103. Applicability of chapter.| (a) This chapter does not apply to:  (i) Persons rendering medical assistance without compensation at the scene of an emergency;  (ii) Medical students trained in an L.C.M.E. or A.O.A. accredited or board approved school of medicine serving as clinical clerks, residents or interns under the supervision of a physician licensed in this state;  (iii) Commissioned medical officers of the United States armed services and medical officers of the United States public health service or the United States department of veterans affairs in the discharge of their official duties or within federally controlled facilities or enclaves, provided that the persons who are licensees of the board shall be subject to the provisions of this act and further provided that all such persons shall be the holder of a full and unrestricted license to practice medicine in one (1) or more jurisdictions of the United States;  (iv) Any individual residing in and licensed in good standing to practice medicine in another state or country brought into this state for consultation by a physician licensed to practice medicine in this state, provided the physician licensed in this state notifies the board of the consultation in compliance with regulations adopted by the board;  (v) Any individual licensed to practice medicine in another state who comes to this state to remove human organs from brain-dead persons;  (vi) The treatment of disease, injury, deformity or ailments by prayer or spiritual means provided that federal and state health and sanitation laws, rules and regulations are not violated;  (vii) The gratuitous domestic administration of family remedies;  (viii) Health care providers licensed under any other chapter of this title engaged in the practice of the profession for which he is licensed;  (ix) Repealed By Laws 2003, Ch. 190, § 3.  (x) Any person who does not represent himself to be a licensed health care professional who offers health care advice or nonprescription medicine to another person in a social or educational situation in any manner otherwise lawful.
WY Stat § 33-26-201 (2021)
2021 Wyoming Statutes|Title 33 - Professions and Occupations|Chapter 26 - Physicians and Surgeons|Article 2 - Wyoming State Board of Medicine|Section 33-26-201 - State Board of Medicine; Composition; Appointment; Terms; Qualifications; Removal; Vacancies; Quorum.

33-26-201. State board of medicine; composition; appointment; terms; qualifications; removal; vacancies; quorum.| (a) The Wyoming state board of medicine shall consist of five (5) physicians licensed to practice medicine in Wyoming, not less than one (1) of whom shall possess the degree of doctor of osteopathy and not less than two (2) of whom shall possess the degree of doctor of medicine, one (1) physician assistant and two (2) lay members, appointed by the governor by and with the consent of the senate as required by W.S. 28-12-101 through 28-12-103. Board members appointed by the governor shall serve at the pleasure of the governor. The board members shall annually elect a president, a vice-president, and a secretary.  (b) Board members shall serve four (4) year terms. No board member shall serve more than three (3) consecutive terms.  (c) Physician and physician assistant members shall reside in, hold a full and unrestricted license and actively practice in this state. Lay members shall reside in this state.  (d) The governor shall appoint a new board member if a vacancy occurs. A person appointed to fill a vacancy shall serve for the unexpired portion of the vacated term. A vacancy occurs if a member:  (i) Is absent from three (3) consecutive meetings;  (ii) No longer holds a full and unrestricted license to practice in this state or no longer engages in active practice in this state;  (iii) Resigns; or  (iv) Is removed by the governor.  (e) A quorum of the board consists of five (5) board members, including a lay member, unless otherwise specified in subsection (f) of this section.  (f) If the board president determines that due to conflicts of interest or other circumstances it may not be possible to seat a quorum of board members to hear a disciplinary case brought pursuant to this act, the president may submit a written request to the governor for the appointment of one (1) or more acting board members to hear the disciplinary case in question. Upon receipt of the request, the governor shall appoint the requested number of temporary board members for the sole purpose of hearing the disciplinary case in question. Only persons who previously served as members of the board shall be eligible for temporary appointment to hear disciplinary cases before the board. Appointments made under this subsection shall not require the consent of the senate pursuant to W.S. 28-12-101 through 28-12-103. Persons appointed pursuant to this subsection shall be compensated and have their expenses reimbursed in the same manner as regular board members under W.S. 33-26-203(c). The appointment of a person under this subsection shall automatically terminate upon the entering of a final order in the disciplinary case for which he was appointed.